Brompheniramine-Pseudoephedrine-Dextromethorphan Syrup for Cold and Flu Symptoms
This combination syrup is effective for symptomatic relief of rhinorrhea, nasal congestion, and cough associated with the common cold, but should be avoided in patients with uncontrolled hypertension, cardiovascular disease, or those taking other sympathomimetic agents. 1
Medication Components and Mechanism
Each 5 mL contains three active ingredients that target different cold symptoms 1:
- Brompheniramine maleate 2 mg: First-generation antihistamine that reduces rhinorrhea, sneezing, and post-nasal drip through H1-receptor blockade and anticholinergic effects 2, 3
- Pseudoephedrine hydrochloride 30 mg: Oral decongestant that reduces nasal congestion through α-adrenergic-mediated vasoconstriction 4, 5
- Dextromethorphan hydrobromide 10 mg: Antitussive that suppresses cough 1, 6
Evidence for Efficacy
Brompheniramine demonstrates significant efficacy for rhinovirus colds, reducing nasal secretion weights (4.3g vs 6.8g on day 1, P≤0.03), rhinorrhea scores, sneeze counts (1.8 vs 3.6 on day 1, P≤0.001), and total symptom scores compared to placebo 3. The American College of Chest Physicians recommends first-generation antihistamines like brompheniramine over newer agents for cold symptoms specifically due to their anticholinergic properties that better control rhinorrhea 2.
Pseudoephedrine 60 mg demonstrates objective decongestant efficacy, with significantly lower nasal airway resistance compared to placebo after both single dose (P=0.006) and multiple doses (P<0.001) 5. The combination of pseudoephedrine with other agents provides complementary symptom relief 7.
Dosing Recommendations
Adults and children over 12 years: 5 mL (1 teaspoonful) every 4-6 hours, not exceeding 4 doses in 24 hours 1, 8
Children 6-12 years: Reduced doses (typically half the adult dose) with physician consultation recommended 8
Children under 4 years: Should not receive over-the-counter cold medications without healthcare provider consultation first 9
Critical Contraindications and Precautions
Cardiovascular Considerations
Patients with uncontrolled hypertension must avoid this medication due to pseudoephedrine's vasoconstrictive effects 4. While pseudoephedrine increases systolic blood pressure by only approximately 1 mmHg in most patients, this effect is clinically significant in those with uncontrolled hypertension or specific cardiovascular conditions 4.
The American College of Cardiology recommends avoiding oral decongestants in severe or uncontrolled hypertension, suggesting alternatives such as intranasal corticosteroids, nasal saline irrigation, or antihistamines alone instead 4.
Patients with controlled hypertension can generally use pseudoephedrine safely at standard doses, but blood pressure monitoring is recommended due to interindividual variation 4.
Additional High-Risk Populations
Use with extreme caution or avoid in patients with 8, 4:
- Arrhythmias or coronary artery disease
- Cerebrovascular disease
- Hyperthyroidism
- Closed-angle glaucoma
- Bladder neck obstruction or prostatic hypertrophy
Drug Interactions and Combinations
Never combine with other sympathomimetic decongestants, as this can potentially lead to hypertensive crisis due to combined vasoconstrictive effects 4.
Avoid concurrent caffeine use, which may produce additive adverse effects including elevated blood pressure, insomnia, irritability, and palpitations 4.
Common Adverse Effects
Antihistamine-Related (Brompheniramine)
- Sedation and performance impairment that may exist without subjective awareness, affecting school and driving performance 2
- These effects cannot be eliminated by bedtime-only administration due to prolonged plasma half-life 2
- Anticholinergic effects including dry mouth, urinary retention, constipation 8
Sympathomimetic-Related (Pseudoephedrine)
- Insomnia and irritability 8
- Palpitations and tachycardia (heart rate increases by 2.83 beats/min on average) 4
- Blood pressure elevation 4
- Nervousness (reported in 4% of pseudoephedrine users) 7
Safer Alternatives for High-Risk Patients
For patients with uncontrolled hypertension or cardiovascular disease, the American College of Cardiology and American Heart Association recommend 4:
- Intranasal corticosteroids (safest and most effective first-line option)
- Second-generation antihistamines alone (loratadine, cetirizine, fexofenadine) without pseudoephedrine
- Nasal saline irrigation (completely safe without systemic effects)
- Topical nasal decongestants (oxymetazoline) for ≤3 days maximum if absolutely necessary
Clinical Pearls
The combination provides complementary effects: brompheniramine addresses histamine-mediated symptoms and rhinorrhea through anticholinergic properties, pseudoephedrine targets nasal congestion, and dextromethorphan suppresses cough 2, 1.
Treatment duration should be limited to symptomatic relief only, typically 3-5 days for acute cold symptoms 5.
Aspirin-containing products must never be administered to persons aged ≤18 years with suspected influenza due to Reye's syndrome risk; use acetaminophen or NSAIDs for fever instead 9.